Cervical Adenosquamous Carcinoma — Trials

Cervical Adenosquamous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02257528	Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer	active not recruiting	Phase 2	26	National Cancer Institute (NCI)NIH	1	Sep 8, 2026	clinicaltrials
NCT07153952	RT for Adenocarcinoma/Adenosquamous Carcinoma	active not recruiting	Phase 1 / Phase 2	60	Peking Union Medical College HospitalOTHER	1	Sep 4, 2025	clinicaltrials